Careful consideration when responding to new data: dolutegravir and pregnancy

Careful consideration when responding to new data: dolutegravir and pregnancy

This case highlights the current complexities of managing women in the early stages of pregnancy presenting on dolutegravir-based regimens. When responding to new data, there is an important decision to be made, between the potential, uncertain risk of teratogenicity against the potential increased...

Full description

Bibliographic Details
Main Authors: C. Foster, S. Fidler, E.G.H. Lyall, G.P.T. Taylor
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Journal of Virus Eradication
Subjects:
dolutegravir, pregnancy, treatment switch
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020302624
id doaj-ae3ae7fb8d424cd79d2ddeff67f4ad32
record_format Article
spelling doaj-ae3ae7fb8d424cd79d2ddeff67f4ad322021-05-05T04:05:06ZengElsevierJournal of Virus Eradication2055-66402018-07-0143208Careful consideration when responding to new data: dolutegravir and pregnancyC. Foster0S. Fidler1E.G.H. Lyall2G.P.T. Taylor3Imperial College Healthcare NHS Trust, London, UK; Corresponding author: Caroline Foster, Imperial College Healthcare NHS Trust, London, W2 1NY, UKImperial College Healthcare NHS Trust, London, UK; Imperial College, London, UKImperial College Healthcare NHS Trust, London, UKImperial College Healthcare NHS Trust, London, UK; Imperial College, London, UKThis case highlights the current complexities of managing women in the early stages of pregnancy presenting on dolutegravir-based regimens. When responding to new data, there is an important decision to be made, between the potential, uncertain risk of teratogenicity against the potential increased risk of in utero vertical transmission of HIV-1.http://www.sciencedirect.com/science/article/pii/S2055664020302624dolutegravir, pregnancy, treatment switch
collection DOAJ
language English
format Article
sources DOAJ
author C. Foster
S. Fidler
E.G.H. Lyall
G.P.T. Taylor
spellingShingle C. Foster
S. Fidler
E.G.H. Lyall
G.P.T. Taylor
Careful consideration when responding to new data: dolutegravir and pregnancy
Journal of Virus Eradication
dolutegravir, pregnancy, treatment switch
author_facet C. Foster
S. Fidler
E.G.H. Lyall
G.P.T. Taylor
author_sort C. Foster
title Careful consideration when responding to new data: dolutegravir and pregnancy
title_short Careful consideration when responding to new data: dolutegravir and pregnancy
title_full Careful consideration when responding to new data: dolutegravir and pregnancy
title_fullStr Careful consideration when responding to new data: dolutegravir and pregnancy
title_full_unstemmed Careful consideration when responding to new data: dolutegravir and pregnancy
title_sort careful consideration when responding to new data: dolutegravir and pregnancy
publisher Elsevier
series Journal of Virus Eradication
issn 2055-6640
publishDate 2018-07-01
description This case highlights the current complexities of managing women in the early stages of pregnancy presenting on dolutegravir-based regimens. When responding to new data, there is an important decision to be made, between the potential, uncertain risk of teratogenicity against the potential increased risk of in utero vertical transmission of HIV-1.
topic dolutegravir, pregnancy, treatment switch
url http://www.sciencedirect.com/science/article/pii/S2055664020302624
work_keys_str_mv AT cfoster carefulconsiderationwhenrespondingtonewdatadolutegravirandpregnancy
AT sfidler carefulconsiderationwhenrespondingtonewdatadolutegravirandpregnancy
AT eghlyall carefulconsiderationwhenrespondingtonewdatadolutegravirandpregnancy
AT gpttaylor carefulconsiderationwhenrespondingtonewdatadolutegravirandpregnancy
_version_ 1721475853816168448

Similar Items